Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Seyyed Morteza Hosseini Imeni has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Seyed-Hashem Daryabari

    Department of Ophthalmology, Baqiyatallah University of Medical Sciences, Tehran, Iran

    5 shared publications
  • Seyed-Hashem Daryabari

    Department of Ophthalmology, Baqiyatallah University of Medical Sciences, Mollasadra Street, Tehran, No. 14359 15371, Iran

    3 shared publications
  • Saeed Karimi

    Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran

    2 shared publications
  • Ali Bahramifar

    Trauma Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran

    1 shared publication
  • Amin Solouki

    Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran

    1 shared publication
  • Behnam Hosseini Ahangar

    Gastroenterology and Liver Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran

    1 shared publication

Latest Publications

  • Open Access

    Efficacy of Combined Intravitreal Bevacizumab and Dexamethasone Compared to Bevacizumab Alone for Treatment of Persistent Macular Edema Secondary to Retinal Vein Occlusion

    by Saeed Karimi, Fatemeh Farahani, Seyed-Hashem Daryabari, Seyyed-Morteza Hosseini Imeni

    Purpose: This study evaluated the short-term anatomical and visual outcomes and complications of simultaneous intravitreal injection of bevacizumab and dexamethasone versus bevacizumab alone in patients with persistent macular edema caused by retinal vein occlusion (RVO) admitted at Labbafinejad Medical Center. Methods: This prospective interventional study was performed on 50 eyes from 50 patients with RVO-related macular edema refractory to at least three monthly bevacizumab injections. The eligibility criteria included central macular thickness (CMT) >300 μm and <10% reduction from baseline. Patients were alternately allocated to two groups: one received monthly bevacizumab (1.25 mg) alone (monotherapy group) and the other received intravitreal bevacizumab combined with dexamethasone (200 μg) for three sessions (combination group). Best-corrected visual acuity (BCVA), CMT, and intraocular pressure (IOP) were measured at baseline and 1 month after the third injection. Results: Baseline CMT was 511.4 ± 139.05 μm in the combination group, which decreased to 417.58 ± 156.72 μm 1 month after the last injection (P = 0.004), while the reduction of CMT was not significant in the monotherapy group. In comparison, combination therapy yielded a significantly greater CMT reduction than bevacizumab monotherapy (P = 0.020). BCVA improved significantly from baseline only in the combination group (P = 0.016), though the difference in visual improvement between groups was not significant (P = 0.457). In patients with central retinal vein occlusion (CRVO), CMT reduction was notably greater with combination therapy (P = 0.015) compared to branch retinal vein occlusion (BRVO). Visual and anatomical improvements were comparable between BRVO and CRVO subgroups. Combination therapy did not increase the risk of elevated IOP. Conclusion: For treatment-resistant macular edema secondary to RVO, simultaneous intravitreal bevacizumab and dexamethasone could reduce CMT and improve BCVA more effectively than bevacizumab alone, without increasing IOP. Given the cost and limited access to dexamethasone implants, adjunctive intravitreal dexamethasone solution is a viable option for persistent macular edema secondary to RVO.

  • Open Access

    Evaluation of COVID-19 severity and post-acute-COVID-19 sequelae of dry eye disease in patients with SARS-CoV-2 infection

    by Seyed-Hashem Daryabari, Seyed Aliasghar Mosavi, Seyed Morteza Hosseini Imeni, Neda Shajirat

    Objective: To evaluate the prevalence and severity of dry eye disease in patients with a history of COVID-19 infection. Methods: A total of 76 patients who had recovered from COVID-19 were included in the study. Dry eye disease was assessed using subjective and objective measures, including the Ocular Surface Disease Index questionnaire, tear break-up time, Schirmer test, and corneal staining. Results: This study included 76 patients with a mean age of 54.55 ± 10.61 years. The results revealed a [...] ABSTRACT Objective: To evaluate the prevalence and severity of dry eye disease in patients with a history of COVID-19 infection. Methods: A total of 76 patients who had recovered from COVID-19 were included in the study. Dry eye disease was assessed using subjective and objective measures, including the Ocular Surface Disease Index questionnaire, tear break-up time, Schirmer test, and corneal staining. Results: This study included 76 patients with a mean age of 54.55 ± 10.61 years. The results revealed a

  • Open Access

    Unexplained Perivascular Chorioretinal Atrophy: Is Ranolazine a Possible Cause?

    by Saeed Karimi, Mohsen Zare, Pantea Karbasi, Morteza Hosseini

    Purpose: To report a case of unexplained perivascular chorioretinal atrophy temporally associated with ranolazine use. Case Report: A 64-year-old man with chronic stable angina pectoris was referred to our retina clinic with a complaint of an inferior visual field defect in the right eye over the last 1 month. The symptom onset coincided with the prescription of ranolazine extended-release 500 mg daily and slowly progressed over this period. Central and color vision were normal, and relative afferent pupillary defect was negative. Fundus exam showed chorioretinal atrophy in both eyes along the main vascular arcades, which was more prominent in the right eye and along the superior temporal arcade. Visual field assessment disclosed a double arcuate scotoma in both eyes. Swept-source optical coherence tomography showed outer retina, retinal pigment epithelium, and choriocapillaris atrophy in the extrafoveal area. Fundus autofluorescence showed hypo-autofluorescence, and fluorescein angiography revealed staining along the vascular arcades. Electroretinogram disclosed abnormal photopic and scotopic responses. All findings were more prominent in the right eye and along the superior temporal arcade. Ranolazine intake was stopped. Three months after drug cessation, the patient’s visual field and electroretinogram improved. Conclusion: This is the first case report on ranolazine-associated chorioretinal toxicity, highlighting the necessity of further studies on potential side effects of even short-term exposure to this drug.


  • Formulation of treatment protocol for ocular surface squamous neoplasia

    by Seyed-Hashem Daryabari, Hossein Aghamollaei, Seyed Rahim Hassanpour, Javad Rezaei, Seyyed Morteza Hosseini Imeni, Mojtaba Sepandi, Mehdi Raei

    In this study we report a structured, evidence-based treatment protocol for ocular surface squamous neoplasia (OSSN) by integrating findings from a systematic literature review with expert clinical insights. We performed a two-step methodology. First, a comprehensive systematic review was conducted using PubMed, Scopus, and Web of Science to identify relevant studies on OSSN treatment. Articles were screened based on predefined inclusion and exclusion criteria. Next, a focused group discussion was conducted with expert ophthalmologists to develop a consensus-driven treatment protocol. Discussions were transcribed and thematically analyzed to identify key recommendations for treatment selection and follow-up strategies. Based on the literature review and expert panel consensus, a structured treatment protocol was developed. Surgical treatment is recommended in cases with uncertainty regarding the diagnosis, resource limitations, exclusive corneal involvement, and poor patient compliance with medical treatment or follow-up. Medical treatment with interferon α-2b or 5-fluorouracil is preferred in other scenarios, with agent selection based on side-effect profile and medication availability. Adjuvant therapy is advised when surgical margins are involved. Furthermore, a standardized follow-up schedule is proposed, ensuring long-term monitoring for recurrence. In conclusion, this protocol provides a structured, adaptable framework for OSSN treatment, offering clear guidelines for selecting the appropriate treatment strategy. By balancing evidence-based recommendations with clinical considerations, this protocol aims to optimize patient outcomes.

  • Effect of suction angle on zonular fibers during residual cortex removal in phacoemulsification using finite element modeling

    by Seyed Hashem Daryabari, Seyyed Morteza Hosseini Imeni, Mojtaba Ghouhestani

    Purpose: To evaluate the effect of suction direction on zonular fibers' mechanical behavior using finite element modeling. Setting: Laboratory study. Design: 3D finite element model experimental study. Methods: A 3D finite element model was developed, including nucleus covered by cortex and capsule. Similar to cataract surgery, a circular rapture was considered at the top of the capsule to apply suction pressure. Finally, zonular fibers were modeled as a continuum body using 3D solid elements (C3D8R). A custom FORTRAN subroutine was implemented to enforce tension-only behavior, mimicking the physiological characteristics of the zonular fibers, which are resistant to tensile but not compressive loads. This method allows for a realistic simulation of zonular mechanics during cortical aspiration. Results: The suction processes in tangential and normal angles were simulated. The resulting relative displacements between the cortex and capsule, as a criterion of cortex separation, vs the resulting maximum zonule displacements, were recorded in each model. The cortex–capsule relative displacement vs maximum zonule displacement indicated a diagram slope of 0.09 for tangential applying pressure and 0.02 in the case of applying normal pressure. Conclusions: The results illustrated that zonular fibers were less tensile in a specific magnitude of cortex–capsule relative displacement under tangential applying pressure, which means that eye zonular fibers have a lower risk of failure until the separation of the lens cortex.


  • Placental-Derived Products for Corneal Regeneration: Applications of Amniotic Membrane, Cord Blood Serum, and Stem Cells: A Review

    by Seyed-Hashem Daryabari, Melina Ghasemian, Ehsan Lotfi, Amin Solouki, Kaili Lin, Tahereh Manoochehrabadi, Seyyed Morteza Hosseini Imeni, Hadi Esmaeili Gouvarchin Ghaleh


  • Open Access

    The Effect of Fasting on Anterior Segment Parameters: A Systematic Review

    by Seyed-Hashem Daryabari, Ali Bahramifar, Behnam Hosseini Ahangar, Saeed Karimi, Neda Shajirat, Seyyed Morteza Hosseini Imeni

    Purpose: To ascertain the effect of Ramadan fasting on the anterior segment. Fasting can affect anterior segment parameters because of altered hydration and metabolism. Methods: We searched online databases such as PubMed, Cochrane Library, Web of Science, Scopus, Embase, and Google Scholar for relevant records by suitable keywords. Overall, 21 eligible articles were included for the final assessment. Outcomes included types of fasting, tear film, corneal biomechanics, anterior chamber parameters, refraction, and visual acuity. Results: All 21 articles were conducted after Ramadan fasting. The outcomes revealed that tear breakup time (TBUT) diminished and basal tear secretion (BTS) decreased. Predawn fluid intake temporarily improved tear production. A study revealed that ocular surface disease index (OSDI) scores degraded. Increases in tear osmolarity and inflammatory markers were reported. Transient corneal steepening and reduced corneal hysteresis suggested dehydration effects, while advanced imaging revealed posterior curvature changes. Furthermore, inconsistent results included diminished or augmented anterior chamber depth. No significant changes were reported in refraction or visual acuity. Conclusions: The results indicated that fasting could alter various ocular structures and functions in the eye. Fasting could change the ocular surface condition, especially during the hotter seasons and longer fasting periods, along with lower parameters such as TBUT, BTS, and result in higher ocular discomfort, as measured by indices such as the OSDI scores. In addition, although the refraction and visual acuity seem to be stable along the fasting period, fasting could alter keratometric values and intraocular lens calculation, leading to suboptimal refractive results after surgeries.

  • Treatment Efficacy in Herpes Zoster Ophthalmoplegia: A Systematic Review and Meta‐Analysis of Case Reports and Series

    by Mansoor Shahriari, Sadra Ashrafi, Seyyed Morteza Hosseini Imeni, Saeed Mohammad Soleymani, Hadi Esmaily

    Varicella zoster virus (VZV) causes herpes zoster ophthalmicus (HZO), a disease resulting from VZV reactivation in the eye branch of the trigeminal nerve, primarily affecting the elderly or immunocompromised. Current research on the relative prevalence of ocular HZO is limited to case series and reports. This study aims to conduct a systematic review and meta‐analysis comparing the effects of antiviral drugs, corticosteroids, and their combination in published cases of ophthalmoplegic HZO. We reviewed the Scopus, PubMed, and Google Scholar databases for HZO‐related studies, analysing all case reports and case series interventional studies. Our initial search yielded 14,100 articles, with 92 articles encompassing 111 patients included in the final analysis. Steroid treatment showed a greater improvement in visual score compared to antiviral treatment ( ß = 0.80, 95% CI = 0.10, 1.50 = 1.10, p = 0.024). We found no significant relationship between treatment type and extraocular movement improvement ( p > 0.05). While corticosteroid administration timing did not correlate with extraocular movement improvement ( p = 0.108), increased acyclovir duration was associated with 3.64 times higher odds of improvement (OR = 3.64, 95% CI = 1.004, 13.23, p = 0.049). Patients with myositis had 19.42 times higher odds of skin involvement after orbital symptoms compared to those with orbital apex syndrome (OAS) (OR = 19.42, 95% CI = 1.16, 325.05, p = 0.039). Our findings suggest corticosteroid treatment may be more effective for visual outcomes than antiviral drugs or combination therapy. Additionally, longer antiviral therapy duration is linked to better extraocular motor outcomes. Most ophthalmoplegic HZO patients exhibited signs of aseptic meningitis in cerebrospinal fluid (CSF) examinations.


  • Open Access

    Strip meniscometry in dry eye disease: correlations with standard diagnostic tests

    by Seyed-Hashem Daryabari, Mohammad Majid Ali-Akbari, Seyyed Morteza Hosseini Imeni

    Background: Dry eye disease (DED) is a multifactorial condition with a globally rising prevalence. Diagnosis relies on both symptoms and clinical tests, but these methods demonstrate variability. Strip meniscometry (SMTube) represents a rapid, non-invasive alternative method, but its diagnostic value remains uncertain. We evaluated the correlation of its findings with those of established DED evaluations. Methods: In this cross-sectional study, we recruited 100 individuals with and without DED (n = 50 each) who visited a tertiary ophthalmology clinic. Diagnosis of DED was based on symptomatology and standard criteria, including a tear break-up time (TBUT) < 5 s or Schirmer test I result < 5 mm, along with an Ocular Surface Disease Index (OSDI) score > 12 and corneal fluorescein staining grade > 1. The exclusion criteria included ocular surgery, allergy, or contact lens use. All participants underwent comprehensive ophthalmic examination and standardized DED assessments (OSDI, tear meniscus height [TMH], SMTube, TBUT, corneal fluorescein staining, and Schirmer test I), conducted in a controlled setting by a single examiner during 9–11 AM to ensure consistency. Results: The DED group was significantly older (P < 0.05). No significant sex difference was observed between groups (P > 0.05). The OSDI, TMH, SMTube, TBUT, corneal fluorescein staining, and Schirmer test I findings differed significantly (all P < 0.001), while SMTube application discomfort rates were similar between groups (P > 0.05). In the DED group, SMTube correlated moderately with TBUT (r = + 0.41, P < 0.05) and OSDI (r = + 0.43, P < 0.05), while the Schirmer test I correlated weakly with TBUT (r = + 0.34, P < 0.05) and moderately with TMH (r = + 0.52, P < 0.05). In the controls, no significant correlations were observed between tear metrics and SMTube or Schirmer test I findings (all P > 0.05), except for corneal fluorescein staining, which showed a weak negative correlation with SMTube (r = - 0.28, P < 0.05) and a moderate positive correlation with Schirmer test I findings (r = + 0.51, P < 0.05). Conclusions: SMTube findings differed significantly between the DED and control groups and correlated moderately with those of established diagnostic assessments, particularly the TBUT and OSDI. Unlike Schirmer testing, SMTube results are closely associated with symptom severity, suggesting its utility in reflecting patient-reported discomfort. Given its simplicity, non-invasiveness, and correlation with key clinical indicators, SMTube may serve as a valuable adjunct in the multimodal assessment of DED. However, further studies are needed to establish its diagnostic accuracy and to confirm its clinical utility.

  • Ophthalmologic trauma following the pager explosion in Lebanon

    by Seyed-Hashem Daryabari, Seyyed Morteza Hosseini Imeni, Seyyed Rahim Hassanpour